These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9640983)

  • 1. [Results of long-term observation (3-11 years) of patients with dual diagnosis: body dysmorphic disorder and delusional disorder, somatic type].
    Rabe-Jabłońska J
    Psychiatr Pol; 1998; 32(2):143-53. PubMed ID: 9640983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clomipramine vs desipramine crossover trial in body dysmorphic disorder: selective efficacy of a serotonin reuptake inhibitor in imagined ugliness.
    Hollander E; Allen A; Kwon J; Aronowitz B; Schmeidler J; Wong C; Simeon D
    Arch Gen Psychiatry; 1999 Nov; 56(11):1033-9. PubMed ID: 10565503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of fluvoxamine in body dysmorphic disorder.
    Phillips KA; Dwight MM; McElroy SL
    J Clin Psychiatry; 1998 Apr; 59(4):165-71. PubMed ID: 9590666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysmorphophobia: body dysmorphic disorder or delusional disorder, somatic subtype?
    de Leon J; Bott A; Simpson GM
    Compr Psychiatry; 1989; 30(6):457-72. PubMed ID: 2684497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delusionality and response to open-label fluvoxamine in body dysmorphic disorder.
    Phillips KA; McElroy SL; Dwight MM; Eisen JL; Rasmussen SA
    J Clin Psychiatry; 2001 Feb; 62(2):87-91. PubMed ID: 11247107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placebo-controlled study of pimozide augmentation of fluoxetine in body dysmorphic disorder.
    Phillips KA
    Am J Psychiatry; 2005 Feb; 162(2):377-9. PubMed ID: 15677604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Body dysmorphic disorder: clinical picture, diagnostic criteria, prevalence, course and treatment].
    Rabe-Jabłońska J
    Psychiatr Pol; 1998; 32(2):133-42. PubMed ID: 9640982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An open trial of paroxetine for the "offensive subtype" of taijin kyofusho and social anxiety disorder.
    Nagata T; van Vliet I; Yamada H; Kataoka K; Iketani T; Kiriike N
    Depress Anxiety; 2006; 23(3):168-74. PubMed ID: 16456863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obsessive-compulsive disorder in relation to body dysmorphic disorder.
    Tanquary J; Lynch M; Masand P
    Am J Psychiatry; 1992 Sep; 149(9):1283-4. PubMed ID: 1482445
    [No Abstract]   [Full Text] [Related]  

  • 10. A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder.
    Phillips KA; Albertini RS; Rasmussen SA
    Arch Gen Psychiatry; 2002 Apr; 59(4):381-8. PubMed ID: 11926939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body dysmorphic disorder in the DSM-IV field trial for obsessive-compulsive disorder.
    Simeon D; Hollander E; Stein DJ; Cohen L; Aronowitz B
    Am J Psychiatry; 1995 Aug; 152(8):1207-9. PubMed ID: 7625473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insight, overvalued ideation, and delusional thinking in body dysmorphic disorder: theoretical and treatment implications.
    Phillips KA; McElroy SL
    J Nerv Ment Dis; 1993 Nov; 181(11):699-702. PubMed ID: 8228952
    [No Abstract]   [Full Text] [Related]  

  • 13. [Dysmorphophobia].
    Mehler-Wex C; Warnke A
    MMW Fortschr Med; 2006 Mar; 148(10):37-9. PubMed ID: 16612948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body image disturbance in body dysmorphic disorder and eating disorders. Obsessions or delusions?
    Phillips KA; Kim JM; Hudson JI
    Psychiatr Clin North Am; 1995 Jun; 18(2):317-34. PubMed ID: 7659601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Liaison between body dysmorphic disorder and eating disorders].
    Rabe-Jabłońska J
    Psychiatr Pol; 1998; 32(2):155-63. PubMed ID: 9640984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body dysmorphic disorder and the DSM-IV: the demise of dysmorphophobia.
    Munro A; Stewart M
    Can J Psychiatry; 1991 Mar; 36(2):91-6. PubMed ID: 2044041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dysmorphophobia (body dysmorphic disorder)].
    Filteau MJ; Pourcher E; Baruch P; Bouchard RH; Vincent P
    Can J Psychiatry; 1992 Sep; 37(7):503-9. PubMed ID: 1423148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapy for body dysmorphic disorder: treatment received and illness severity.
    Phillips KA; Pagano ME; Menard W
    Ann Clin Psychiatry; 2006; 18(4):251-7. PubMed ID: 17162625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clomipramine treatment of delusional disorder-somatic type.
    Sondheimer A
    J Am Acad Child Adolesc Psychiatry; 1988 Mar; 27(2):188-92. PubMed ID: 3360722
    [No Abstract]   [Full Text] [Related]  

  • 20. Body dysmorphic disorder: 30 cases of imagined ugliness.
    Phillips KA; McElroy SL; Keck PE; Pope HG; Hudson JI
    Am J Psychiatry; 1993 Feb; 150(2):302-8. PubMed ID: 8422082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.